Astrazeneca has a market cap of 177.38 Billion USD which is a 98.93% higer valuation than Semtech
Astrazeneca has a 98.19% higer revenue than Semtech, the last quarter (Year to year) Astrazeneca revenue is up 31% and Semtech is up 13.1%
Astrazeneca's profit is 27.61 Billion and Semtech's profit 466.08 Million the last quarter. That results in Astrazeneca's Profit being -45.1% lower and Semtech's profit is up to 62%. (quarterly year to year)
We are missing info about Astrazeneca's P/E Ratio
Astrazeneca's price to sale ratio is 40.95% higer than Semtech's
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide.
The company is headquartered in Cambridge, the United Kingdom.
Semtech Corporation designs, develops, manufactures, and markets mixed-signal and analog semiconductor products and advanced algorithms.
The company is headquartered in Camarillo, California.
The best Cash App card designs are the ones that inspire creativity. You can use a variety of designs and emojis to make your card stand out. You can be …Read More
Do you struggle to give meaningful gifts to friends and family? Sometimes, it is easiest just to allow them to purchase their own present by gracing them with gift cards. …Read More
Cash App is an incredibly convenient online bank that allows you to transfer money between users with no fees. Not only that, but you can spend all the money in …Read More